27016652Julier Z, de Titta A, Grimm AJ, Simeoni E, Swartz MA, Hubbell JAVaccineCancer Vaccines; Fibronectins; Hepatitis B Vaccines; Oligodeoxyribonucleotides; T-Lymphocytes, Cytotoxic; Th1 Cells; Toll-Like Receptor 4Adjuvants, Immunologic; Animals; Dendritic Cells; Disease Models, Animal; Hepatitis B; Hepatitis B virus; Immunity, Cellular; Immunity, Humoral; Mice; Mice, Transgenic; Receptors, Pattern Recognition; Toll-Like Receptor 9; VaccinationFibronectin EDA and CpG synergize to enhance antigen-specific Th1 and cytotoxic responses. Vaccine. 2016 05 05; 34(21):2453-2459.Vaccine2016-03-24T00:00:002016Fibronectin EDA and CpG synergize to enhance antigen-specific Th1 and cytotoxic responses.prns:emailEncryptedemail addressprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000276Chemicals & Drugs711660.904219Adjuvants, ImmunologicD000818Living Beings1457265180.249646AnimalsJeffreyHubbell3Wp8CaMQFeD5hHlsaUXv9Gq0+s+oJeffrey Hubbell41.7886000000000087.598699999999993473Hubbell, JeffreyBarry L. MacLean ProfessorMelodySwartzMelody Swartz41.7886000000000087.598699999999993497Swartz, MelodyProfessorD003713Anatomy1054240.763412Dendritic CellsAuthorship 1108555Authorship 1108546D005353Chemicals & Drugs54930.939837Fibronectins0.5738040.1434512authors10.2520has subject areaD006509Disorders43720.945768Hepatitis BD007111Physiology1041770.925983Immunity, CellularD008822Living Beings37515370.738477Mice, TransgenicPritzker Institute for Molecular EngineeringD014611Procedures1282530.851971VaccinationD018417Anatomy741640.909756Th1 CellsD009838Chemicals & Drugs631260.968869OligodeoxyribonucleotidesD017325Chemicals & Drugs11130.990539Hepatitis B VaccinesD019496Chemicals & Drugs461560.877627Cancer VaccinesD051192Chemicals & Drugs16190.980196Receptors, Pattern RecognitionD051379Living Beings980113130.368427MiceD056724Physiology43670.93712Immunity, HumoralD013602Anatomy783140.879092T-Lymphocytes, CytotoxicD051197Chemicals & Drugs57880.938266Toll-Like Receptor 4D051217Chemicals & Drugs15200.987675Toll-Like Receptor 9D004195Disorders59222270.60194Disease Models, AnimalD006515Living Beings28420.978708Hepatitis B virusUniversity of Chicagotrue1Barry L. MacLean ProfessorBarry L. MacLean Professortrue1ProfessorProfessor